Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache

Update Il y a 5 ans
Reference: NCT01540799

Woman and Man

Extract

The purpose of the clinical study is to evaluate the use of an implanted sphenopalatine ganglion (SPG) neurostimulator for the treatment of migraine headache pain, migraine headache symptoms and migraine frequency in high disability migraineurs.


Inclusion criteria

  • High Frequency, High Disability Migraine

Links